STATE OF NEW YORK
________________________________________________________________________
6505
2019-2020 Regular Sessions
IN SENATE
June 14, 2019
___________
Introduced by Sens. MARTINEZ, GAUGHRAN -- read twice and ordered print-
ed, and when printed to be committed to the Committee on Rules
AN ACT to amend the public health law, in relation to establishing a cap
on the price of prescription insulin
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. The public health law is amended by adding a new section
2 280-d to read as follows:
3 § 280-d. Prescription insulin price cap. 1. For purposes of this
4 section, "prescription insulin drug" shall mean a prescription drug
5 containing insulin to be used in the treatment of diabetes and that:
6 (a) is required by any applicable federal or state law to be dispensed
7 only pursuant to a prescription; or
8 (b) is restricted by any applicable federal or state law to use by
9 practitioners only.
10 2. Any health insurance carrier that provides coverage for
11 prescription insulin drugs pursuant to the terms of a health insurance
12 policy or health benefits plan shall cap the total cost a covered person
13 is required to pay for a covered prescription insulin drug at an amount
14 not to exceed one hundred dollars per thirty day supply of insulin,
15 regardless of the amount or type of insulin needed to fill such covered
16 person's prescription.
17 3. Nothing in this section shall prevent a health insurance carrier
18 from reducing a covered person's cost for insulin by an amount greater
19 than the amount specified in subdivision two of this section.
20 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD13030-01-9
